From: The impact of comorbidity and stage on ovarian cancer mortality: A nationwide Danish cohort study
Conditions | Total (%) | Charlson score |
---|---|---|
Myocardial infarct | 113 (2.2%) | 1 |
Congestive heart failure | 117 (2.2%) | 1 |
Peripheral vascular disease | 112 (2.2%) | 1 |
Cerebrovascular disease | 229 (4.4%) | 1 |
Dementia | 17 (0.3%) | 1 |
Chronic pulmonary disease | 232 (4.5%) | 1 |
Connective tissue disease | 137 (2.6%) | 1 |
Ulcer disease | 180 (3.5%) | 1 |
Mild liver disease | 47 (0.9%) | 1 |
Diabetes type 1 or type 2 | 124 (2.4%) | 1 |
Hemiplegia | 8 (0.2%) | 2 |
Moderate or severe renal disease | 39 (0.8%) | 2 |
Diabetes with end organ damage type 1 or type 2 | 50 (1.0%) | 2 |
Any tumour (not ovarian cancer) | 490 (9.4%) | 2 |
Leukemia | 9 (0.2%) | 2 |
Lymphoma | 13 (0.3%) | 2 |
Moderate or severe liver disease | 11 (0.2%) | 3 |
Metastatic solid tumour | 160 (3.1%) | 6 |
AIDS | 0 | 6 |